Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies

Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies Dr. Adrian ...

Greenhaven Backs Avantor to Capture the Next Cycle in Life Sciences

Greenhaven Associates has taken a new swing in Avantor, buying roughly $228 million worth of Avantor (AVTR) stock after a ...
Business Insider

Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences

NEW YORK and CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a royalty interest in Alnylam’s AMVUTTRA from funds managed by ...
IEEE

Blockchain Technology for Authentic Product Identification in the Medical and Pharmaceutical Sector Using QR code and NFT (QR-NFT)

Abstract: Counterfeit products remain a pervasive challenge, undermining consumer trust and impacting global supply chains. In the pharmaceutical and healthcare sectors, counterfeit drugs pose a ...